520A — J-Pharma Co Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for J-Pharma Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2024 March 31st | 2025 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | JAS | JAS |
| Status: | Final | Final |
| Net Income/Starting Line | -1,651 | -1,498 |
| Depreciation | ||
| Non-Cash Items | 191 | -89.4 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 47.1 | -108 |
| Change in Accounts Receivable | ||
| Change in Prepaid Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -1,411 | -1,695 |
| Capital Expenditures | -13.4 | -0.191 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | -16.4 | — |
| Acquisition of Business | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -29.7 | -0.191 |
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 925 | 2,924 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -514 | 1,229 |